Erasca, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Erasca, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
-5.7×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 54% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 2/3Sales grew in 0 of the last 3 years; profit grew in 2 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-18.8×Operating cash was negative last year, while some debt falls due within a year.
Lower than 53% of Healthcare companies in United States.
Cash Cushion Ratio
+5%Cash, after subtracting all debt, equals 5% of its market value (net cash).
Lower than 58% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
Erasca, Inc. made a loss over the last year. Erasca, Inc. owes $0.17 for every $1 it owns. Erasca, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossErasca, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
13.91The share price is 13.91 times Erasca, Inc.'s book value per share, higher than 90% of Healthcare companies in United States.
Market cap
$5.0 BThe total market value of all of Erasca, Inc.'s shares at today's price (share price × number of shares), larger than 84% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$362 MWhat Erasca, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.03Net worth divided by the number of shares. The share price of $14.39 is 13.9 times this, which is the P/B above.
Return on equity (ROE)
-78.2%Erasca, Inc. lost 78.2% of its shareholders' money over the last year, lower than 64% of Healthcare companies in United States.
Owes vs Owns
0.17×Erasca, Inc. owes $0.17 for every $1 it owns (low), lower than 78% of Healthcare companies in United States.
Dividend yield
NoneErasca, Inc. does not currently pay a dividend.
Profit growth
LossErasca, Inc. made a loss in each of the last two years.
Cash vs debt
Net cashErasca, Inc. held $229 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Erasca, Inc.: $5.0 B ÷ $362 M (30 Jun 2026) = 13.9.
What is Erasca, Inc.'s return on equity?
Erasca, Inc. lost 78.2% of its shareholders' money over the last year, lower than 64% of Healthcare companies in United States.
How much does Erasca, Inc. owe compared with what it owns?
Erasca, Inc. owes $0.17 for every $1 it owns (low), lower than 78% of Healthcare companies in United States.
Does Erasca, Inc. pay a dividend?
No. Erasca, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.